(LB) LandBridge - Overview
Stock: Land, Royalties, Water, Materials
EPS (Earnings per Share)
Revenue
Dividends
| Dividend Yield | 0.65% |
| Yield on Cost 5y | 1.74% |
| Yield CAGR 5y | 0.00% |
| Payout Consistency | 100.0% |
| Payout Ratio | 47.1% |
| Risk 5d forecast | |
|---|---|
| Volatility | 63.0% |
| Relative Tail Risk | -6.53% |
| Reward TTM | |
|---|---|
| Sharpe Ratio | 0.03 |
| Alpha | -41.59 |
| Character TTM | |
|---|---|
| Beta | 1.677 |
| Beta Downside | 1.897 |
| Drawdowns 3y | |
|---|---|
| Max DD | 48.25% |
| CAGR/Max DD | 1.58 |
Description: LB LandBridge January 10, 2026
LandBridge Company LLC (NYSE: LB) is a Houston-based real-estate operating company that acquires, holds, and manages surface land and mineral rights to facilitate oil and natural-gas production, primarily in the Delaware Basin of West Texas and New Mexico.
Founded in 2021, the firm’s core assets include surface acres adjacent to prolific shale plays, a portfolio of royalty interests that generate cash flow tied to production volumes, and a niche business selling brackish water and other surface-derived materials to energy operators.
Key performance indicators that investors watch include: (1) acreage growth rate (the company added ~12,000 net acres in Q4 2023); (2) royalty-based revenue per barrel of oil equivalent (ROE), which has risen to $0.42 / BOE as oil prices have recovered; and (3) water-sale volume, which reached 1.8 million gallons per month in early 2024, reflecting heightened demand for low-salinity water in hydraulic-fracturing.
Sector-level drivers remain strong: U.S. shale output is projected to grow ~3 % YoY in 2025, supported by continued drilling activity in the Permian and Delaware basins, while water-management constraints are pushing operators toward on-site brackish-water sourcing-a niche where LandBridge has a first-mover advantage.
For a deeper, data-rich view of LandBridge’s valuation metrics and comparable peers, consider exploring the ValueRay platform’s analyst toolkit.
Piotroski VR‑10 (Strict, 0-10) 6.0
| Net Income: 24.3m TTM > 0 and > 6% of Revenue |
| FCF/TA: 0.10 > 0.02 and ΔFCF/TA 2.85 > 1.0 |
| NWC/Revenue: 24.36% < 20% (prev -10.50%; Δ 34.86% < -1%) |
| CFO/TA 0.11 > 3% & CFO 115.1m > Net Income 24.3m |
| Net Debt (-27.4m) to EBITDA (112.7m): -0.24 < 3 |
| Current Ratio: 4.15 > 1.5 & < 3 |
| Outstanding Shares: last quarter (76.5m) vs 12m ago 4.60% < -2% |
| Gross Margin: 92.65% > 18% (prev 0.90%; Δ 9175 % > 0.5%) |
| Asset Turnover: 20.23% > 50% (prev 16.08%; Δ 4.15% > 0%) |
| Interest Coverage Ratio: 3.32 > 6 (EBITDA TTM 112.7m / Interest Expense TTM 30.9m) |
Altman Z'' 1.85
| A: 0.04 (Total Current Assets 57.4m - Total Current Liabilities 13.8m) / Total Assets 1.08b |
| B: 0.02 (Retained Earnings 18.0m / Total Assets 1.08b) |
| C: 0.12 (EBIT TTM 102.5m / Avg Total Assets 883.9m) |
| D: 0.72 (Book Value of Equity 272.0m / Total Liabilities 380.1m) |
| Altman-Z'' Score: 1.85 = BBB |
Beneish M -2.15
| DSRI: 0.82 (Receivables 19.7m/14.9m, Revenue 178.8m/110.9m) |
| GMI: 0.97 (GM 92.65% / 90.24%) |
| AQI: 2.17 (AQ_t 0.10 / AQ_t-1 0.04) |
| SGI: 1.61 (Revenue 178.8m / 110.9m) |
| TATA: -0.08 (NI 24.3m - CFO 115.1m) / TA 1.08b) |
| Beneish M-Score: -2.15 (Cap -4..+1) = BB |
What is the price of LB shares?
Over the past week, the price has changed by +4.46%, over one month by +20.37%, over three months by -24.25% and over the past year by -22.28%.
Is LB a buy, sell or hold?
- StrongBuy: 2
- Buy: 3
- Hold: 3
- Sell: 0
- StrongSell: 0
What are the forecasts/targets for the LB price?
| Issuer | Target | Up/Down from current |
|---|---|---|
| Wallstreet Target Price | 73 | 28.7% |
| Analysts Target Price | 73 | 28.7% |
| ValueRay Target Price | 57.9 | 2.1% |
LB Fundamental Data Overview February 04, 2026
P/E Forward = 21.5983
P/S = 24.1686
P/B = 6.1114
Revenue TTM = 178.8m USD
EBIT TTM = 102.5m USD
EBITDA TTM = 112.7m USD
Long Term Debt = 366.1m USD (from longTermDebt, last quarter)
Short Term Debt = 924.0k USD (from shortTermDebt, last quarter)
Debt = 924.0k USD (from shortLongTermDebtTotal, last quarter)
Net Debt = -27.4m USD (from netDebt column, last quarter)
Enterprise Value = 4.29b USD (4.32b + Debt 924.0k - CCE 28.3m)
Interest Coverage Ratio = 3.32 (Ebit TTM 102.5m / Interest Expense TTM 30.9m)
EV/FCF = 38.22x (Enterprise Value 4.29b / FCF TTM 112.4m)
FCF Yield = 2.62% (FCF TTM 112.4m / Enterprise Value 4.29b)
FCF Margin = 62.84% (FCF TTM 112.4m / Revenue TTM 178.8m)
Net Margin = 13.59% (Net Income TTM 24.3m / Revenue TTM 178.8m)
Gross Margin = 92.65% ((Revenue TTM 178.8m - Cost of Revenue TTM 13.1m) / Revenue TTM)
Gross Margin QoQ = 94.05% (prev 91.38%)
Tobins Q-Ratio = 3.98 (Enterprise Value 4.29b / Total Assets 1.08b)
Interest Expense / Debt = 853.8% (Interest Expense 7.89m / Debt 924.0k)
Taxrate = 11.76% (2.71m / 23.0m)
NOPAT = 90.4m (EBIT 102.5m * (1 - 11.76%))
Current Ratio = 4.15 (Total Current Assets 57.4m / Total Current Liabilities 13.8m)
Debt / Equity = 0.00 (Debt 924.0k / totalStockholderEquity, last quarter 272.0m)
Debt / EBITDA = -0.24 (Net Debt -27.4m / EBITDA 112.7m)
Debt / FCF = -0.24 (Net Debt -27.4m / FCF TTM 112.4m)
Total Stockholder Equity = 353.7m (last 4 quarters mean from totalStockholderEquity)
RoA = 2.75% (Net Income 24.3m / Total Assets 1.08b)
RoE = 6.87% (Net Income TTM 24.3m / Total Stockholder Equity 353.7m)
RoCE = 14.24% (EBIT 102.5m / Capital Employed (Equity 353.7m + L.T.Debt 366.1m))
RoIC = 11.74% (NOPAT 90.4m / Invested Capital 770.5m)
WACC = 12.09% (E(4.32b)/V(4.32b) * Re(12.09%) + (debt cost/tax rate unavailable))
Discount Rate = 12.09% (= CAPM, Blume Beta Adj.)
Shares Correlation 3-Years: 100.0 | Cagr: 129.7%
[DCF Debug] Terminal Value 69.14% ; FCFF base≈88.3m ; Y1≈109.0m ; Y5≈185.6m
Fair Price DCF = 62.02 (EV 1.70b - Net Debt -27.4m = Equity 1.73b / Shares 27.8m; r=12.09% [WACC]; 5y FCF grow 25.0% → 2.90% )
EPS Correlation: 46.38 | EPS CAGR: 73.12% | SUE: 0.08 | # QB: 0
Revenue Correlation: 89.09 | Revenue CAGR: 51.51% | SUE: N/A | # QB: 0
EPS next Quarter (2026-03-31): EPS=0.38 | Chg30d=+0.000 | Revisions Net=+0 | Analysts=1
EPS next Year (2026-12-31): EPS=1.73 | Chg30d=+0.000 | Revisions Net=+0 | Growth EPS=+68.0% | Growth Revenue=+23.9%